Press release
Asia-Pacific Anti-Fungal Drugs Market estimated to reach $2.38 billion by 2021 with a CAGR of 4.1%
The Asia-Pacific ‘Anti-Fungal Drugs Market' research report, published by Market Data Forecast estimates that the market itself was worth $1.94 billion in 2016 and expected to grow at a CAGR of 4.1%, to reach $2.38 billion by 2021.There are several types of antifungal medicines. They come as creams, sprays, solutions, tablets designed to go into the vagina, shampoos, medicines to take by mouth, and injections. Most work by damaging the cell wall of the fungus, which causes the fungal cell to die. People who are prescribed an antifungal injection are usually in hospital and are very ill.
The length of treatment depends on what type of fungal infection you have, how severe it is and if you have any other health problems - for example, problems with your immune system. Some courses of treatment can be as short as a few days while other courses can be a long as eight weeks (eg, for ringworm, infection of the scalp).
Request Free Sample: http://www.marketdataforecast.com/market-reports/asia-pacific-anti-fungal-drugs-market-247/request-sample
The report also presents detailed analysis of multitude of factors affecting the Anti-Fungal Drugs market bearing either positive or negative outcomes.
Some of those factors are:
• Rising awareness of fungal infections with the increasing incidence of antifungal infections all over the world
• Rising government and corporate funding in the industry
• Development of public private partnership in the pharmaceutical industry
• Rising popularity of over-the-counter antifungal drugs for dermal infections
• Increase of population in whom the occurrence of fungal infections is much more than average
• Existing high penetration of conventional drugs used for the treatment of fungal infections
Customize the report: http://www.marketdataforecast.com/market-reports/asia-pacific-anti-fungal-drugs-market-247/customize-report
For granular level understanding the Anti-Fungal Drugs Market is segmented based on product and application, each being provided with Market Size Estimates and Y-o-Y Forecasts. The antifungal drugs market is segmented by drug type into Echinocandins, Azoles, Polyenes, Allylamines and Other Drugs. Also, the market is segmented by type of therapeutic indications into Aspergillosis, Dermatophytosis, Candidiasis, Other therapeutic indications. And the market is also segmented by applications into Powders, Ointments, Drugs, Pastes. While Azoles which include fluconazole, itraconazole, ketoconazole, posaconazole and voriconazole, are systemically acting, Echinocandins which include anidulafungin, caspofungin and micafungin are lipopeptides derived from natural fungal fermentation products and Polyenes which include include amphotericin B deoxycholate and liposomal amphotericin B. Corifungin are systemically acting and disrupts eukaryotic cellular membranes. Azoles segment is the largest segment of the market followed by echinocandins.
Inquire Before Buying: http://www.marketdataforecast.com/market-reports/asia-pacific-anti-fungal-drugs-market-247/inquire
On the basis of geography, the Asia-pacific antifungal drugs market is segmented into the countries China, India, Japan, South Korea. The Antifungal drugs market in Asia-Pacific is the fastest growing followed by Latin America. India antifungal drugs market is the fastest growing in the Asia-pacific region.
Request Discount: http://www.marketdataforecast.com/market-reports/asia-pacific-anti-fungal-drugs-market-247/request-discount
Major market players dominating the market, include Alternaria, Pfizer, Novartis, Sanofi-Aventis, Merck & Co., Asperqillus, Bayer Healthcare, Kramer Laboratories, Enzon Pharmaceuticals, Glaxosmithkline Gilead and Abbott Laboratories.
Checkout other related studies in the Pharmaceuticals Segment:
Anti-fungal drugs Market: http://www.marketdataforecast.com/market-reports/global-anti-fungal-drugs-market-242/
Antivenom Market: http://www.marketdataforecast.com/market-reports/global-antivenom-market-1580/
The Asia-Pacific Anti-Fungal Drugs Market report offers wide-range of scope:
• Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries
• Know more about key areas of industry growth via detailed Segment-level analysis on basis of product type long with market size forecasts and y-o-y estimations
• Detailed explanation of major drivers, restraints, opportunities, and challenges(DROC) that affect the market and impact the ever-shifting market dynamics
• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail:abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asia-Pacific Anti-Fungal Drugs Market estimated to reach $2.38 billion by 2021 with a CAGR of 4.1% here
News-ID: 605241 • Views: …
More Releases from Market Data Forecast

Business Management Consulting Service Market is expected to witness a significa …
According to the latest research report published by Market Data Forecast, the global business management consulting services market is estimated to grow at a CAGR of 4.3% from 2024 to 2029 and be worth USD 1148 bn by 2029 from USD 930.15 bn in 2024.
The demand for consulting services is fuelled by the need for outside help from several enterprises, charitable organizations, and government agencies. Business management consulting advises organizations…

Antimicrobial Coatings Market expected to witness a significant growth rate of 1 …
According to the latest research report published by Market Data Forecast, the global antimicrobial coatings market is expected to grow at a CAGR of 11% during the forecast period 2024-2029. The market value was at USD 5 billion in 2023 and the value is expected to reach USD 9 billion by the end of 2029.
It is applied to stop microorganisms and other bacteria from growing and expanding. These are extensively…

End-User Computing Market Sees Explosive Growth Globally
According to the latest research report published by Market Data Forecast, the global end-user computing market is predicted to reach USD 15.33 billion in 2024 and USD 27.99 billion in 2029, growing at a CAGR of 12.8% during the forecast period.
Today's workforce is moving, with employees looking to access corporate data, apps, and online resources across more devices and locations. While supporting workplace mobility, minimizing risk, and maintaining compliance, end-user…

Smart Homes Market Size, Share, Growth Report 2024-2029
According to the latest research report published by Market Data Forecast, the global smart home market is predicted to reach USD 114.92 billion in 2024 and USD 221.46 billion by 2029, growing at a CAGR of 14.02% during the forecast period.
Advancements in IoT technology, as well as rising consumer demand for convenience and energy efficiency, are driving significant growth in the smart home industry. Smart thermostats, lighting, security systems, and…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…